Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI
Status:
Unknown status
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
In this study, advanced techniques of myocardial nuclear magnetic perfusion scanning were
used to quantitatively assess infarct size after acute myocardial infarction, saved viable
myocardium, and microcirculatory obstruction area. Objectively and quantitatively evaluate
early use of cardiomyopeptidin for direct PCI of ST-segment elevation myocardial infarction.
After the improvement of microcirculation and increase the intervention effect of viable
myocardium.